Open-label Phase I Study for PEP or Treatment of HS-ARS PLX-R18 for the Post-Exposure Prevention (PEP) or Treatment of Hematopoietic Syndrome of Acute Radiation Syndrome (HS-ARS)

Name: Open-label Phase I Study for PEP or Treatment of HS-ARS PLX-R18 for the Post-Exposure Prevention (PEP) or Treatment of Hematopoietic Syndrome of Acute Radiation Syndrome (HS-ARS)
Published: 2021
License: Public Domain

Pluristem Ltd. · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

ionizing radiation exposure, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Open-label Phase I Study for PEP or Treatment of HS-ARS PLX-R18 for the Post-Exposure Prevention (PEP) or Treatment of Hematopoietic Syndrome of Acute Radiation Syndrome (HS-ARS)

Related documents